Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
127.00
-0.80 (-0.63%)
At close: Sep 26, 2025, 3:59 PM
127.00
0.00%
After-hours: Sep 26, 2025, 05:59 PM EDT
Jazz Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.09B | 4.06B | 4.07B | 3.99B | 3.91B | 3.84B | 3.83B | 3.79B | 3.76B | 3.74B | 3.66B | 3.58B | 3.48B | 3.3B | 3.09B | 2.86B | 2.63B | 2.44B |
Cost of Revenue | 461.21M | 454.85M | 445.71M | 424.24M | 414.79M | 402.42M | 435.58M | 495.7M | 527.21M | 553.88M | 540.52M | 509.31M | 520.87M | 515.86M | 440.76M | 354.76M | 251.63M | 160.45M |
Gross Profit | 3.63B | 3.61B | 3.62B | 3.57B | 3.5B | 3.44B | 3.4B | 3.3B | 3.24B | 3.18B | 3.12B | 3.07B | 2.96B | 2.78B | 2.65B | 2.51B | 2.37B | 2.28B |
Operating Income | -291.3M | 594.53M | 716.63M | 648.36M | 560.54M | 518.73M | 578.58M | 192.7M | 45.07M | -27.02M | -65.53M | 247.24M | 250.84M | 95.71M | 170.28M | 294.31M | 462.15M | 729.87M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -512.18M | 361.29M | 468.69M | 396.55M | 295.68M | 237.88M | 294.92M | -106.91M | -269.23M | -330.79M | -382.7M | -89.76M | -97.97M | -251.22M | -113.55M | 78.45M | 316.85M | 621.1M |
Net Income | -404.84M | 482.2M | 560.12M | 463.16M | 394.92M | 330.79M | 414.83M | 80.73M | -85.74M | -155.51M | -223.29M | -18.69M | -51.87M | -449.85M | -329.67M | -160.9M | 40.16M | 518.28M |
Selling & General & Admin | 1.57B | 1.55B | 1.39B | 1.41B | 1.39B | 1.4B | 1.34B | 1.33B | 1.38B | 1.41B | 1.42B | 1.43B | 1.44B | 1.5B | 1.45B | 1.3B | 1.14B | 906.34M |
Research & Development | 811.04M | 841.8M | 884M | 860.11M | 894.59M | 883.1M | 849.66M | 805.61M | 720.07M | 649.88M | 590.45M | 573.34M | 565.51M | 559.16M | 505.75M | 442M | 379.62M | 325.84M |
Other Expenses | 1.54B | 626.03M | 637.31M | 647.96M | 645.39M | 642.23M | 627.28M | 970.12M | 1.09B | 1.16B | 1.18B | 821.87M | 706.79M | 629.67M | 525.77M | 471.55M | 388.43M | 313.93M |
Operating Expenses | 3.92B | 3.02B | 2.91B | 2.92B | 2.93B | 2.92B | 2.82B | 3.11B | 3.19B | 3.21B | 3.18B | 2.83B | 2.71B | 2.69B | 2.48B | 2.21B | 1.91B | 1.55B |
Interest Expense | 211.03M | 225.69M | 238.1M | 257.17M | 269.96M | 281.41M | 289.44M | 293.24M | 301.99M | 291.7M | 288.24M | 302.71M | 315.84M | 322.07M | 278.77M | 217.74M | 151.8M | 108.59M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.38B | 3.47B | 3.35B | 3.34B | 3.35B | 3.32B | 3.26B | 3.6B | 3.72B | 3.77B | 3.72B | 3.34B | 3.23B | 3.2B | 2.92B | 2.57B | 2.16B | 1.71B |
Income Tax Expense | -107.34M | -120.91M | -91.43M | -66.61M | -99.25M | -92.92M | -119.91M | -186.87M | -182.72M | -174.5M | -158.65M | -71.07M | -46.1M | 198.63M | 216.12M | 239.35M | 276.69M | 102.82M |
Shares Outstanding (Basic) | 61.19M | 60.98M | 60.54M | 61.41M | 62.88M | 62.54M | 62.58M | 63.11M | 63.99M | 63.49M | 63.05M | 62.78M | 62.44M | 61.87M | 61.5M | 61.28M | 59.45M | 56.47M |
Shares Outstanding (Diluted) | 61.19M | 60.98M | 61.5M | 63.17M | 69.63M | 62.54M | 69.67M | 71.29M | 73.54M | 73.77M | 63.05M | 62.78M | 63.43M | 62.91M | 61.5M | 61.28M | 59.45M | 58.39M |
EPS (Basic) | -6.6 | 7.82 | 9.11 | 7.45 | 6.28 | 5.23 | 6.55 | 1.24 | -1.4 | -2.47 | -3.53 | -0.29 | -0.84 | -7.51 | -5.38 | -2.42 | 1.11 | 9.29 |
EPS (Diluted) | -6.73 | 7.50 | 8.79 | 7.10 | 5.82 | 4.85 | 6.12 | 0.89 | -1.56 | -2.53 | -3.54 | -0.3 | -0.85 | -7.51 | -5.45 | -2.55 | 0.95 | 9.12 |
EBITDA | 447.1M | 1.32B | 1.45B | 1.45B | 1.36B | 1.31B | 1.39B | 1.41B | 1.37B | 1.37B | 1.37B | 1.47B | 1.37B | 1.13B | 1.03B | 789.85M | 871.6M | 1.06B |
EBIT | -225.43M | 662.2M | 793.37M | 799.35M | 711.53M | 669.73M | 752.09M | 784.25M | 759.96M | 763.32M | 736.9M | 823.02M | 703.28M | 472.7M | 473.73M | 330.31M | 508.15M | 778.87M |
Depreciation & Amortization | 672.53M | 661.56M | 660.07M | 650.85M | 648.18M | 644.72M | 638.7M | 624.23M | 610.49M | 607.12M | 629.47M | 649.36M | 668.11M | 659.22M | 552.48M | 459.54M | 363.45M | 283.85M |